Luminex Corporation To Present At JP Morgan Healthcare Conference

      Luminex Corporation To Present At JP Morgan Healthcare Conference

PR Newswire

AUSTIN, Texas, Jan. 2, 2014

AUSTIN, Texas, Jan. 2, 2014 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX)
today announced that management will present at the 32^nd Annual JP Morgan
Healthcare Conference to be held January 13-16, 2014, in San Francisco, CA.

(Logo: http://photos.prnewswire.com/prnh/20100104/LUMINEXLOGO)

The investor presentation by Patrick J. Balthrop, president and chief
executive officer, will begin at 4:30 p.m. Pacific time (7:30 p.m.
Easterntime) on Wednesday, January 15, 2014. The presentation will
bewebcast live and may be accessed at Luminex Corporation's website at
http://www.luminexcorp.com. Simplylog on to the web at the address above, go
to the Company section and access the Investor Relations link. Please go to
the website at least 15 minutes prior to the event to register, download and
install any necessary audio/video software. If you are unable to participate
during the live webcast, the presentation will be archived for six months on
the website using the 'replay' link.

ABOUT LUMINEX CORPORATION

Luminex is committed to applying its passion for innovation toward advancing
healthcare and research worldwide. The Company is transforming global
healthcare and life-science research through the development, manufacturing
and marketing of proprietary instruments and assays utilizing xMAP^®
open-architecture, multi-analyte platform and MultiCode^® real-time polymerase
chain reaction (PCR) and multiplex PCR-based technologies, that deliver
cost-effective and rapid results to clinicians and researchers. Luminex's
technology is commercially available worldwide and in use in leading clinical
laboratories as well as major pharmaceutical, diagnostic, biotechnology and
life-science companies. The Company is meeting the needs of customers in
markets as diverse as clinical diagnostics, pharmaceutical drug discovery,
biomedical research including genomic and proteomic research, personalized
medicine, bio-defense research and food safety. For further information on
Luminex Corporation and the latest advances in multiplexing using award
winning technology, please visit http://www.luminexcorp.com.

Contacts: Harriss T. Currie
          Sr. Vice President, Finance and CFO
          512-219-8020
          hcurrie@luminexcorp.com
          Matthew Norman
          Government and Investor Relations Manager
          512-219-8020
          mnorman@luminexcorp.com

SOURCE Luminex Corporation

Website: http://www.luminexcorp.com
 
Press spacebar to pause and continue. Press esc to stop.